nausea medicine for semaglutide GLP-1 nausea: How to handle GLP-1s' most common side effect Novo Nordisk medicines containing semaglutide
Description
Park J et al
Researchers discovered that after 68-weeks, those who received semaglutide experienced an average weight loss of 14.9%, while those who received a placebo injection experienced a weight change of only 2.4%
Neuroscientist, 23:454-465
Among patients with Type 2 diabetes, weight reduction averaged only 23% after 72 weeks
doi: 10.3390/pharmaceutics15082163
